Evidence map›Paper›PMID 31724035›Full record

Observational studyThe Journal of infectious diseases2020

Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.

Lauren S Peetluk, Peter F Rebeiro, Marcelo Cordeiro-Santos, Afranio Kritski, Bruno B Andrade, Betina Durovni, Solange Calvacante, María B Arriaga, Megan M Turner, Marina C Figueiredo and 2 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  7. Undernutrition is feeding the tuberculosis pandemic: A perspective.Journal of clinical tuberculosis and other mycobacterial diseases · 2022
    Review
  8. Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Lauren S PeetlukDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Peter F RebeiroDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Marcelo Cordeiro-SantosFundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
Afranio KritskiUniversidade do Estado do Amazonas, Manaus, Brazil.
Bruno B AndradeDivision of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Betina DurovniInstituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Solange CalvacanteInstituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
María B ArriagaMultinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Instituto Brasileiro para Investigação da Tuberculose, Fundação José Silveira, Salvador, Bahia, Brazil.
Megan M TurnerDivision of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Marina C FigueiredoDivision of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Valeria C RollaSecretaria Municipal de Saúde do Rio de Janeiro (Clínica da Familia Rinaldo Delamare)-Rocinha, Rio de Janeiro, Brazil.
Timothy R SterlingDivision of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Vanderbilt University · USFundação Oswaldo Cruz · BRSecretaria Municipal de Saúde · BRFundação de Medicina Tropical · BRInstituto Evandro Chagas · BRUniversidade do Estado do Amazonas · BR

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
NRSA Training CoreTL1TR002244 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$4.6M
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosisR01AI120790 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROLLA, VALERIA CAVALCANTI, STERLING, TIMOTHY R · 2016 to 2019
$2.6M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)TL1TR000447 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$1.2M
The HIV Care Continuum and Health Policy: Changes through Context and GeographyK01AI131895 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI REBEIRO, PETER F · 2017 to 2021
$623k
NCATS NIH HHS TL1 TR000447NCATS NIH HHS TL1 TR002244NIAID NIH HHS K01 AI131895NIAID NIH HHS R01 AI120790NIAID NIH HHS U01 AI069923
6 · The paper itself

Abstract

backgroundWeight change may inform tuberculosis treatment response, but its predictive power may be confounded by human immunodeficiency virus (HIV).

methodsWe prospectively followed up adults with culture-confirmed, drug-susceptible, pulmonary tuberculosis receiving standard 4-drug therapy (isoniazid, rifampin, pyrazinamide, and ethambutol) in Brazil. We examined median weight change 2 months after treatment initiation by HIV status, using quantile regression, and unsuccessful tuberculosis treatment outcome (treatment failure, tuberculosis recurrence, or death) by HIV and weight change status, using Cox regression.

resultsAmong 547 participants, 102 (19%) were HIV positive, and 35 (6%) had an unsuccessful outcome. After adjustment for confounders, persons living with HIV (PLWH) gained a median of 1.3 kg (95% confidence interval [CI], -2.8 to .1) less than HIV-negative individuals during the first 2 months of tuberculosis treatment. PLWH were at increased risk of an unsuccessful outcome (adjusted hazard ratio, 4.8; 95% CI, 2.1-10.9). Weight change was independently associated with outcome, with risk of unsuccessful outcome decreasing by 12% (95% CI, .81%-.95%) per 1-kg increase.

conclusionsPLWH gained less weight during the first 2 months of tuberculosis treatment, and lack of weight gain and HIV independently predicted unsuccessful tuberculosis treatment outcomes. Weight, an easily collected biomarker, may identify patients who would benefit from alternative treatment strategies.

Indexed as

Weight GainAdultAntitubercular AgentsBrazilEthambutolFemaleHIV SeropositivityHumansIsoniazidMaleMiddle AgedProportional Hazards ModelsProspective StudiesPyrazinamideRifampinTime FactorsAntitubercular AgentsEthambutolIsoniazidPyrazinamideRifampinbody weight changesHIVobservational studytreatment outcomeTuberculosis

Identifiers

PMID31724035
PMCPMC7137883
OpenAlexW2994795382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.